KAISER PETER (Chief Development Officer) sold 1.5% of their position (3.01K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $36.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/26/2025ACC: 0001104659-25-116422
Officer· Chief Development Officer
Since Feb 2026
-3.01K
Net shares
Net seller
$36.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.01K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.01K
Price / share
$12.02
Trade value
$36.14K
% of position
1.5%
11/24/2025
194.44K→191.43K
Total
Net shares
−3.01K
Net value
-$36.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2025 | S · Sale | −3.01K | $12.02 | $36.14K | 1.5% | 194.44K | 191.43K |
| Total | −3.01K | -$36.14K | ||||||
Derivative Transactions0
No derivative transactions reported